Clinical-stage biotechnology company Vaxxas has announced the publication of data supporting the potential use of its high-density microarray patch technology to deliver nucleic acid-based vaccines in collaboration with The University of Queensland and Technovalia, an Australian vaccine developer. …
New data supports effective delivery of DNA-based vaccines using patch
March 5, 2025 Australian Biotech
Latest Video
Georgia Forrest
New Stories
-
The race for the Pharma Cup heats up as teams chase the summit
February 8, 2026 - - Latest News -
The leaders will be thinking about this situation like a game of chess
February 7, 2026 - - Latest News -
TrumpRx launches based on global pricing promise in an insurance-dominated reality
February 7, 2026 - - Latest News -
Queensland launches largest free flu vaccination program in Australia
February 6, 2026 - - Latest News -
The 'Dispatched' Week in Review Podcast - 6 February
February 6, 2026 - - Podcast -
AI in healthcare and why doing nothing might be the biggest risk
February 5, 2026 - - Latest News -
An effective example of making the case for reform in a status quo-biased system
February 5, 2026 - - Latest News